Wednesday, March 25, 2015 1:13:12 AM
1.) Positive opinion from the COMP (Committee on Medical Products) regarding its Orphan Medicinal Product Application for Ampligen(R), an experimental therapeutic, to treat Ebola Virus Disease
2.)Positive results against Ebola in vitro, and/or in an animal model, have been reported to the Company by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and other research/academic institutions in the US and abroad. Clinical protocol development is being pursued.
3.)The recent results from USAMRIID compel Hemispherx to move forward its experimental therapeutic Ampligen in the fight against this dread disease plaguing West Africa and to continue to work diligently with the Food and Drug Administration (FDA) and other international organizations committed to the effort to mitigate the ongoing morbidity and mortality of Ebola.
Including the fact that we are going into the conference 25 combined with the WHO reporting for urgent need of Ampligen, government funding around the corner, premarket higher trading then previous day close but we end the day in a Down Day Higher Close bearish candle??? WTF.
Well initially I thought we are dealing with a bunch of shorts holding the stock back but the short as of yesterday is only 0.16% of the total float about 350,000 shares. So this stock should break back to close the December 2012 gab. This week we should see HEB break most of all the resistance lines. You guys have been here for a while. What am I missing, what am I not seeing.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM